Global private equity major The Carlyle Group will acquire 20% stake in Ajay Piramal-owned Piramal Group’s pharmaceutical business for ₹3,700 crore.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in